High Frequency Stimulation Data Matters

This presentation explores the clinical value of 10 kHz high-frequency spinal cord stimulation (HF-SCS) for treating various chronic pain conditions, including non-surgical refractory back pain, diabetic peripheral neuropathy, and chronic abdominal pain. The speaker reviews pivotal studies demonstrating long-term pain relief and functional improvements, highlighting data integrity, trial design, and superior outcomes compared to traditional paresthesia-based systems.

High Frequency Stimulation Data Matters

Published on June 09, 2025

This presentation explores the clinical value of 10 kHz high-frequency spinal cord stimulation (HF-SCS) for treating various chronic pain conditions, including non-surgical refractory back pain, diabetic peripheral neuropathy, and chronic abdominal pain. The speaker reviews pivotal studies demonstrating long-term pain relief and functional improvements, highlighting data integrity, trial design, and superior outcomes compared to traditional paresthesia-based systems. Additionally, he introduces new technologies for phantom limb pain and ultra-high-frequency peripheral stimulation. The session emphasizes the need for wider adoption of advanced waveforms, given their efficacy and reduced explant rates, particularly for underserved and complex pain populations.

Description

This presentation explores the clinical value of 10 kHz high-frequency spinal cord stimulation (HF-SCS) for treating various chronic pain conditions, including non-surgical refractory back pain, diabetic peripheral neuropathy, and chronic abdominal pain. The speaker reviews pivotal studies demonstrating long-term pain relief and functional improvements, highlighting data integrity, trial design, and superior outcomes compared to traditional paresthesia-based systems. Additionally, he introduces new technologies for phantom limb pain and ultra-high-frequency peripheral stimulation. The session emphasizes the need for wider adoption of advanced waveforms, given their efficacy and reduced explant rates, particularly for underserved and complex pain populations.

Reviews

There are no reviews yet.

Be the first to review “High Frequency Stimulation Data Matters”